Baricitinib phosphate, 1g

Baricitinib phosphate (INCB-028050, LY-3009104) is a selective JAK1and JAK2inhibitor with IC50 of 5.9 nM and 5.7 nM, ~70 and ~10-fold selective versus JAK3 and Tyk2, no inhibition to c-Met and Chk2. Baricitinib is found to reduce or interrupt the passage of the virus into target cells and is used in the treatment research for COVID-19.